M. Jeremy Levin's most recent trade in Ovid Therapeutics Inc was a trade of 1,650,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc | Jeremy M. Levin | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,650,000 | 1,650,000 | - | - | Employee Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Jeremy M. Levin | Director, CEO | Purchase of securities on an exchange or from another person at price $ 2.76 per share. | 18 Mar 2024 | 18,248 | 3,616,715 (7%) | 0% | 2.8 | 50,364 | Common Stock |
| Ovid Therapeutics Inc | M. Jeremy Levin | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Levin M. Jeremy | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Dec 2023 | 573,275 | 3,598,467 (7%) | 1% | 0 | Common Stock | |
| Ovid Therapeutics Inc | Jeremy M. Levin | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Dec 2023 | 573,275 | 4,171,742 (8%) | 1% | 0 | Common Stock | |
| Ovid Therapeutics Inc | Jeremy M. Levin | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Jeremy M. Levin | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 423,244 | 423,244 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Jeremy M. Levin | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Jeremy M. Levin | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) |